Virus News and Research

Latest Virus News and Research

New project outlines the epidemiological characteristics of SARS-CoV-2

Independent group leaders Eleanor Scerri and Denise Kuehnert of the Max Planck Institute for the Science of Human History (MPI-SHH) have teamed up with other colleagues from the institute and beyond to comment in Nature Ecology & Evolution on the future of field-based sciences in a COVID-19 world.

15 Sep 2020

Analysis of COVID-19 spread from China, Italy and Iran

A recent study looked at the patterns of the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China, Iran, and Italy to other nations. The study by researchers at Case-Western Reserve University School of Medicine and Duke University is published on the preprint website medRxiv* in September 2020.

15 Sep 2020

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

Pandemics caused by novel infectious agents like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Zika, or Ebola virus seriously impact human health and lives while also overwhelming health care systems all over the world. Early detection and diagnosis allow isolation of the infected patients and contact tracing, which can mitigate the spread of the virus and save lives, especially when a significant number of the patients are asymptomatic.

14 Sep 2020

NIH and FDA examine serious side effect that surfaced in COVID vaccine trial

The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.

14 Sep 2020

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

Myotonic dystrophy type I is the most common type of adult-onset muscular dystrophy. People with the condition inherit repeated DNA segments that lead to the toxic buildup of repetitive RNA, the messenger that carries a gene's recipe to the cell's protein-making machinery.

14 Sep 2020

Rheumatology providers and patient advocates urge lawmakers to address healthcare challenges

The American College of Rheumatology will hold its first virtual Advocates for Arthritis event on Tuesday, Sept. 15, where more than 120 rheumatologists, rheumatology health professionals, and patient advocates will meet with lawmakers via video to discuss the healthcare challenges they are facing in the midst of COVID-19.

14 Sep 2020

Smoke from wildfires may increase COVID-19 risk

The smoke the firefighters are breathing is heightening their risk of contracting the new coronavirus, with potentially life-threatening effects. Further, fighting the huge fires may make infection control measures such as hand washing and social distancing, challenging to perform.

14 Sep 2020

Oxford University and AstraZeneca resume COVID-19 vaccine trial

More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.

14 Sep 2020

Tiny antibody component shows high potency in SARS-CoV-2 animal models

University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19.

14 Sep 2020

Circadian rhythm affects SARS-CoV-2 infection and host immune response

In an interesting bioRxiv preprint paper, French researchers show that the time day can affect infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as guide subsequent host immune response – implying that circadian rhythm may well be a novel target for managing viral progression.

14 Sep 2020

Keto diet could be beneficial for elderly COVID-19 patients

A recent study by researchers at Yale School of Medicine, New York University Langone Health and Washington University School of Medicine, claims that the ketogenic diet (high fat, low carbohydrate diet) is capable of mitigating clinical outcomes of coronavirus disease 2019 (COVID-19) in elderly people by improving immune-metabolic functions and reducing inflammation. The study is currently available on the bioRxiv* preprint server.

14 Sep 2020

Children's Hospital Los Angeles is U.S. site for new study of SARS-CoV-2 spread within households

One of the mysteries about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is how it is spread within households, including why some family members develop the viral infection and others do not.

14 Sep 2020

Computational models screen for coronaviruses likely to infect humans

The researchers from Rochester Institute of Technology and the Hauptmann-Woodward Medical Research Institute produced models of the receptor-binding domain (RBD) found on outbreak strains of betacoronaviruses and its interaction with the host cell receptor angiotensin-converting enzyme 2 (ACE2).

14 Sep 2020

Toyonaka Municipal Hospital reports successful control of COVID-19

Researchers at Toyonaka Municipal Hospital in Japan have shown that the rate of subclinical infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among staff at the hospital is no higher than among the general population in the same area.

14 Sep 2020

Sticky DNA webs may cause tissue damage associated with severe COVID-19 infections

Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine.

14 Sep 2020

Should a COVID-19 vaccine be mandatory for children?

As the search for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine continues, with some candidate vaccines nearing the completion Phase III clinical trials, a trio of experts weighs in with some sound reasoning as to whether any future vaccine should be considered mandatory for children. The viewpoint article is published in the journal JAMA Pediatrics in September 2020.

14 Sep 2020

Researchers identify microRNA molecules that could repress the replication of human coronaviruses

HSE University researchers have found microRNA molecules that are potentially capable of repressing the replication of human coronaviruses, including SARS-CoV-2.

14 Sep 2020

Sleep apnea patients could be at increased risk of adverse outcomes from COVID-19

People who have been diagnosed with obstructive sleep apnoea could be at increased risk of adverse outcomes from COVID-19 according to a new study from the University of Warwick.

14 Sep 2020

Single-molecule imaging of SARS-CoV-2 spikes on virus particles

Using single-molecule FRET analysis, a team of researchers has revealed how the different conformations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein are interconnected. Figuring out the different conformations in real-time and which conformations antibodies prefer may help design effective vaccines and drugs. The research is published on the preprint server bioRxiv*.

14 Sep 2020

Balancing COVID-19 risk with educational benefits in school reopening decisions

Now a new study by researchers at the Institute for Disease Modeling and published on the preprint server medRxiv* in September 2020 focuses on modeling the potential risk of COVID-19 for school students and staff if schools are re-opened in a range of scenarios. This could guide further research on the health and educational outcomes of school reopenings.

14 Sep 2020

Virus News and Research

Latest Virus News and Research

New project outlines the epidemiological characteristics of SARS-CoV-2

Analysis of COVID-19 spread from China, Italy and Iran

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

NIH and FDA examine serious side effect that surfaced in COVID vaccine trial

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

Rheumatology providers and patient advocates urge lawmakers to address healthcare challenges

Smoke from wildfires may increase COVID-19 risk

Oxford University and AstraZeneca resume COVID-19 vaccine trial

Tiny antibody component shows high potency in SARS-CoV-2 animal models

Circadian rhythm affects SARS-CoV-2 infection and host immune response

Keto diet could be beneficial for elderly COVID-19 patients

Children's Hospital Los Angeles is U.S. site for new study of SARS-CoV-2 spread within households

Computational models screen for coronaviruses likely to infect humans

Toyonaka Municipal Hospital reports successful control of COVID-19

Sticky DNA webs may cause tissue damage associated with severe COVID-19 infections

Should a COVID-19 vaccine be mandatory for children?

Researchers identify microRNA molecules that could repress the replication of human coronaviruses

Sleep apnea patients could be at increased risk of adverse outcomes from COVID-19

Single-molecule imaging of SARS-CoV-2 spikes on virus particles

Balancing COVID-19 risk with educational benefits in school reopening decisions

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in